Krystal Biotech Inc (KRYS)
Debt-to-assets ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — |
Total assets | US$ in thousands | 1,055,840 | 818,355 | 558,450 | 626,295 | 310,844 |
Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,055,840K
= 0.00
Based on the data provided, Krystal Biotech Inc's debt-to-assets ratio has consistently been at 0.00 from December 31, 2020, to December 31, 2024. A debt-to-assets ratio of 0.00 indicates that the company has no debt in relation to its total assets during the period analyzed. This may suggest that Krystal Biotech Inc has been funding its operations and investments primarily through equity or internal funds rather than relying on borrowed capital. A lower debt-to-assets ratio is generally seen as a positive indicator of financial health, as it signifies lower financial risk and potentially greater financial stability for the company.
Peer comparison
Dec 31, 2024